Safety, Pharmacodynamics (PD), Pharmacokinetics (PK) Study of SHP141 in 1A, 1B, or 2A Cutaneous T-Cell Lymphoma (CTCL)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2012 by Shape Pharmaceuticals, Inc..
Recruitment status was  Active, not recruiting
The Leukemia and Lymphoma Society
Therapeutics, Inc.
Veristat, Inc.
Information provided by (Responsible Party):
Shape Pharmaceuticals, Inc. Identifier:
First received: September 9, 2011
Last updated: February 12, 2014
Last verified: February 2012
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2014
  Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)